Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submission-Reference-Cited by-同舟云学术

Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submission

Published:2021-09-18 Issue:6 Volume:88 Page:997-1007
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

González-Sales Mario,Djebli Nassim^ORCID,Meneses-Lorente Georgina,Buchheit Vincent,Bonnefois Guillaume,Tremblay Pierre-Olivier,Frey Nicolas,Mercier François

Funder

F. Hoffmann-La Roche Ltd

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-021-04353-8.pdf

Reference29 articles.

1. Amatu A, Sartore-Bianchi A, Siena S (2016) NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open 1:e000023

2. Aisner DL, Nguyen TT, Paskulin DD et al (2014) ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers. Mol Cancer Res 12:111–118

3. Bergethon K, Shaw AT, Ou SH et al (2012) ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 30:863–870